YOLFTbeta
Filana Therapeutics, Inc.

Filana Therapeutics, Inc.

FLNA · NASDAQ · Healthcare / Biotechnology

0.43USD-0.02 (-4.02%)

Price History

Full chart

Market Stats

Previous Close0.448
Open0.46
Day Range0.42 – 0.47
52-Week Range0.67 – 4.98
Volume318.40K
Market Cap37.33M
P/E (TTM)0.00
Forward P/E151.52
EPS-0.75
Dividend Yield0.00%
Beta-0.70
50-Day Avg0.8996
200-Day Avg1.58

About

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Richard Jon Barry
  • Employees17
  • Headquarters6801 N. Capital of Texas Highway, Austin, TX, United States, 78731, USA
  • Websitehttps://www.filanatx.com

Leadership

  • Mr. Richard Jon BarryCEO, President & Director · b. 1959
  • Mr. Eric J. SchoenChief Financial Officer · b. 1968
  • Mr. R. Christopher Cook J.D.Chief Operating & Legal Officer · b. 1964
  • Dr. George Thornton Ph.D.Senior Vice President of Technology
  • Mr. Michael ZamlootSenior Vice President of Technical Operations
  • Jaren LandenChief Clinical Development Officer
  • Dr. Angelique Bordey Ph.D.Senior Vice President of Neuroscience
  • Mr. Jack Moore Ph.D.Senior Vice President of Clinical Development
  • Dr. Joseph Hulihan M.D.Chief Medical Officer · b. 1956
  • Ms. Nancy TeasdaleHead of Regulatory Affairs

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-0000
Cost of Revenue----936.00K
Gross Profit-----936.00K
Operating Expense----94.45M
Operating Income-32.87M-80.02M-105.96M-141.45M-95.39M
EBITDA-31.85M-80.18M-105.80M-141.15M-90.04M
Net Income-32.38M-76.25M-97.22M-24.34M-90.97M
R&D24.81M68.03M89.42M69.64M26.59M

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-234.83M151.66M157.53M118.36M
Total Liabilities-7.29M14.20M11.83M43.95M
Total Equity-227.54M137.47M145.70M74.40M
Cash-201.01M121.14M128.57M95.50M
Net Debt-----95.50M

Cash Flow

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-77.51M-82.03M-116.93M-32.25M
Investing Cash Flow----581.00K
Financing Cash Flow47.80M2.56M124.47M-239.00K
Capital Expenditure2.71M414.00K103.00K581.00K
Free Cash Flow-80.23M-82.44M-117.03M-32.83M
FCF to OCF103.50%100.50%100.09%101.80%

Earnings

Report DateAug 11, 2000Nov 9, 2000Dec 31, 2000May 10, 2001Aug 9, 2001Nov 9, 2001May 10, 2002Aug 8, 2002Nov 7, 2002Feb 26, 2003Apr 24, 2003Jul 22, 2003Oct 21, 2003Jan 27, 2004Apr 22, 2004Jul 20, 2004Oct 19, 2004Jan 26, 2005Apr 21, 2005Jul 26, 2005Nov 2, 2005Jan 17, 2006May 4, 2006Aug 9, 2006Oct 25, 2006Feb 5, 2007May 2, 2007Aug 9, 2007Nov 1, 2007Feb 7, 2008May 7, 2008Jul 30, 2008Oct 29, 2008Feb 5, 2009Apr 30, 2009Aug 4, 2009Oct 29, 2009Jan 28, 2010Apr 28, 2010Jul 28, 2010Oct 28, 2010Feb 3, 2011Apr 27, 2011Aug 4, 2011Nov 3, 2011Feb 9, 2012May 8, 2012Aug 2, 2012Nov 8, 2012Feb 6, 2013Apr 24, 2013Aug 1, 2013Oct 31, 2013Feb 4, 2014May 6, 2014Aug 5, 2014Oct 31, 2014Feb 17, 2015May 7, 2015Jul 23, 2015Nov 10, 2015Mar 1, 2016May 6, 2016Jul 20, 2016Oct 20, 2016Feb 17, 2017Apr 26, 2017Aug 9, 2017Nov 1, 2017Feb 5, 2018May 9, 2018Jul 26, 2018Oct 30, 2018Mar 25, 2019Apr 29, 2019Aug 12, 2019Oct 29, 2019Mar 26, 2020May 6, 2020Aug 12, 2020Nov 9, 2020Mar 23, 2021Apr 21, 2021Aug 3, 2021Nov 10, 2021Mar 1, 2022May 5, 2022Aug 4, 2022Nov 7, 2022Feb 28, 2023May 1, 2023Aug 3, 2023Nov 7, 2023Feb 28, 2024May 13, 2024Aug 8, 2024Nov 7, 2024Mar 3, 2025May 8, 2025Aug 14, 2025Nov 12, 2025Mar 12, 2026May 7, 2026Jul 29, 2026Nov 11, 2026
EPS Estimate-2.80-1.78--1.71-1.61-1.85-1.38-1.43-1.47--1.14-1.21-1.45-1.40-1.84-2.03-1.89-1.74-1.62-1.57--1.270.350.270.490.06-0.140.140.500.270.430.952.51-0.02-0.12-0.40-0.21-0.28-0.21-0.210.49--0.14-0.14-0.14-0.14-0.07-0.07-0.07-0.10--0.07-0.07-0.07----------------------0.12-0.16-0.14--0.06-0.07--0.08-0.13-0.16--0.43-0.49-0.51--0.56-0.58-0.90-0.40--0.40-0.88-0.68---0.27-0.30-0.23-0.22-
EPS Actual-2.80-1.54-1.48-0.63-0.84-0.91-0.98-0.91-0.91-1.33-1.19-1.12-1.47-1.33-2.03-1.82-1.82-1.54-1.40-1.61-1.40-0.490.140.211.40-0.911.960.490.490.140.42-0.142.45-0.21-0.28-0.01-0.21-0.07-0.14-0.14-0.14-1.50-0.04-0.21-0.14-0.070.00-0.02-0.21-0.28-0.06-0.07-0.145.04-0.54-0.50-0.55-0.33-0.40-0.52-0.57-0.69-0.89-0.46-0.54-0.39-0.42-0.64-0.40-0.37-0.33-0.36-0.11-0.04-0.08-0.06-0.04-0.09-0.05-0.05-0.06-0.09-0.09-0.13-0.24-0.35-0.44-0.48-0.51-0.47-0.58-0.63-0.61-0.50-0.43-1.28-0.58-0.57-0.48-0.92-0.22-0.26-0.21-0.18-
Surprise0.00%13.48%-63.16%47.83%50.81%28.99%36.36%38.10%--4.39%7.44%-1.38%5.00%-10.33%10.34%3.70%11.49%13.58%-2.55%-61.42%-60.00%-22.22%185.71%-1616.67%1500.00%250.00%-2.00%-48.15%-2.33%-114.74%-2.39%-950.00%-133.33%98.60%0.00%75.00%33.33%33.33%-128.57%-71.43%-50.00%0.00%50.00%106.71%71.00%-200.00%-180.00%-0.00%-100.00%7300.00%---------------------50.00%75.00%35.71%-16.67%14.29%--12.50%0.00%-50.00%--2.33%2.04%0.00%--3.57%-8.62%32.22%-25.00%--220.00%34.09%16.18%--18.52%13.33%8.70%18.18%-
TimingPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market---------------------Pre-marketPre-marketAfter-hours-After-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market--Pre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap37.33M
Enterprise Value-32.92M
Trailing P/E0.00
Forward P/E151.52
PEG Ratio1.62
Price / Sales2.54
Price / Book0.78
EPS-0.75
Book Value1.32
Revenue (TTM)0
Gross Profit (TTM)-15.65M
EBITDA-12.69M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-55.79%
Return on Assets-7.14%
Shares Outstanding48.31M
Shares Float47.32M
Beta-0.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
26.72%
Insiders
2.05%
Retail / Other
71.23%

Top Institutional Holders

  • Marshall Wace Asset Management Ltd
    2.01M4.17%
  • Vanguard Capital Management, LLC
    1.93M4.00%
  • Two Sigma Investments LLC
    1.71M3.54%
  • BlackRock Inc
    1.41M2.93%
  • Geode Capital Management, LLC
    596.24K1.23%
  • D. E. Shaw & Co LP
    485.02K1.00%
  • GMT Capital Corp
    450.10K0.93%
  • Susquehanna International Group, LLP
    447.28K0.93%
  • Renaissance Technologies Corp
    326.76K0.68%
  • Group One Trading, LLC
    302.62K0.63%
  • Acadian Asset Management LLC
    284.21K0.59%
  • Vanguard Fiduciary Trust Co
    273.93K0.57%
  • GSA Capital Partners LLP
    269.41K0.56%
  • State Street Corp
    239.99K0.50%
  • Jane Street Group LLC
    225.16K0.47%
  • Jacobs Levy Equity Management, Inc.
    209.08K0.43%
  • Northern Trust Corp
    149.19K0.31%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.37M2.83%
  • Fidelity Extended Market Index
    254.14K0.53%
  • iShares Micro-Cap ETF
    147.61K0.31%

Dividends

20121×
5.25Dec 13, 2012
20101×
14.00Dec 13, 2010

Stock Splits

  • May 10, 20171:7